Centene Q1 Commercial Revenue, Membership Fall 6%; CEO Cites Sicker Patients, Buyouts Continue
CNC has more than doubled off its 52-week low of $25.075.
Summary
Centene reported a 6% year-over-year drop in Q1 commercial revenue and a 6% decline in total health-plan membership to 26.3 million. The CEO attributed these declines to higher medical costs from a sicker patient mix and falling Marketplace membership. This news provides more specific, negative details on Q1 performance, adding nuance to the overall 'strong' Q1 results reported in April SEC filings. The company is also continuing its voluntary staff buyout program for most of its 61,000 employees, a cost-cutting measure previously reported by Reuters yesterday. These membership and revenue declines, alongside significant cost-cutting, highlight ongoing operational challenges and pressure on profitability.
At the time of this announcement, CNC was trading at $63.24 on NYSE in the Life Sciences sector, with a market capitalization of approximately $31.3B. The 52-week trading range was $25.08 to $66.55. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.